Irregularities in the Aβ clearance pathway are thought to initiate Aβ and tau protein accumulation in specific brain regions and consequent toxic events that lead to synaptic dysfunction and neurodegeneration in AD. The gene discussed is MAPT; the disease is Alzheimer disease.